This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Wall Street Bulls Look Optimistic About Grab (GRAB): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Grab (GRAB) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
GRABNo Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Intuit (INTU) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Intuit (INTU) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
INTUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Comfort Systems (FIX) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Comfort Systems (FIX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
FIXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is ASML (ASML) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in ASML (ASML). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ASMLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Carvana (CVNA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Carvana (CVNA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CVNAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About PulteGroup (PHM): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), PulteGroup (PHM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PHMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think GE Vernova (GEV) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), GE Vernova (GEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
GEVNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Uber (UBER): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Uber (UBER) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
UBERPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is AbbVie (ABBV) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for AbbVie (ABBV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ABBVPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Rio Tinto (RIO): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Rio Tinto (RIO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
RIONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Walmart (WMT) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Walmart (WMT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
WMTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Western Digital (WDC) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Western Digital (WDC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
WDCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in VALE (VALE) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in VALE (VALE). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
VALEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think ServiceNow (NOW) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), ServiceNow (NOW) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NOWPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About RTX (RTX): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in RTX (RTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
RTXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Leidos (LDOS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Leidos (LDOS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
LDOSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Ares Capital (ARCC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Ares Capital (ARCC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ARCCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is MicroStrategy (MSTR) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for MicroStrategy (MSTR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MSTRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Merck (MRK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MRKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Oracle (ORCL) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Oracle (ORCL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ORCLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About AT&T (T): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), AT&T (T) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
TPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Abercrombie (ANF) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Abercrombie (ANF). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ANFNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Adobe (ADBE) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Adobe (ADBE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ADBEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
VKTXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in ARKO (ARKO) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in ARKO (ARKO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ARKONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth